ZNF217 and breast cancer: Interestingly, our previous work demonstrated that ZNF217, a transcriptional activator of TGF-β, is a target of miR-200c in breast cancer cells8 and promotes epithelial-to-mesenchymal transition (EMT) in breast cancer23.